Arcturus Therapeutics
ARCT
$18.21
Share price
-3.77%
Change (1 day)
-61.46%
Change (1 year)
Arcturus Therapeutics (ARCT) - Cash on Hand
Cash on Hand as of December 2024 : C$0.33 Billion
According to Arcturus Therapeutics
's latest financial reports the company has C$0.33 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Arcturus Therapeutics - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | C$0.34 B | -12.18% |
| 2023-12-31 | C$0.38 B | -27.17% |
| 2022-12-31 | C$0.53 B | 12.62% |
| 2021-12-31 | C$0.47 B | -20% |
| 2020-12-31 | C$0.59 B | 533.35% |
| 2019-12-31 | C$93.19 M | 86.36% |
| 2018-12-31 | C$50 M | -18.12% |
| 2017-12-31 | C$61.06 M | 444.55% |
| 2016-12-31 | C$11.21 M | -84.05% |
| 2015-12-31 | C$70.3 M | 179.2% |
| 2014-12-31 | C$25.18 M | -52.79% |
| 2013-12-31 | C$53.33 M | 55193.81% |
| 2012-12-31 | C$0.09 M | -83.42% |
| 2011-12-31 | C$0.58 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | C$6.03 M | -98.21% | 🇺🇸 USA |
 | C$0.18 M | -99.94% | Bahamas |